General Advance — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Synchronsynchron.com in 𝕏Jun 2021

Synchron develops brain-computer interface technology delivered via catheter to restore or improve motor and cognitive function in people with impairment or decline.

BiotechDeep TechMedical DevicesCampbell, US

Thomas James Oxley(Executive Officer, Director)Nicholas Opie(Director)in Thomas Oxley(Founder)in

BoardRahul Sharma(Director)Alex Morgan(Director)inMartin Dieck(Director)

Co-investorsARCH Venture Partners Forepont Capital Partners ID8 Investments Kaleida Capital Khosla Ventures Alumni Ventures +11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.